Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP335522.RAfylJlXdxx8en7805Ojvj2huCpCAy-NSVixSO4Py8Q70130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP335522.RAfylJlXdxx8en7805Ojvj2huCpCAy-NSVixSO4Py8Q70130_provenance.
• NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP282867.RAtCEoX6_Mp2xz-Ea9Ox7hf3m60WbFCuFEkIzbQ-qHeLA130_provenance.
• NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP671511.RArhPeRVHE_f2qmoNq50fGjx7blC-lmeoXA-z8rZCF-00130_provenance.
• NP574791.RAmJkh33Tv_eYqa329WyJWhwEAwLgQxSC13DY-x5fKzhw130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP574791.RAmJkh33Tv_eYqa329WyJWhwEAwLgQxSC13DY-x5fKzhw130_provenance.
• NP260988.RAVZM-efCzSGYLartERt6TBbGYAHWnkUIgyV6yKyEiZ8c130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260988.RAVZM-efCzSGYLartERt6TBbGYAHWnkUIgyV6yKyEiZ8c130_provenance.
• assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP227385.RA-buws6cSpYxYKB3zCQ-CH2RN5lsZqE3QwGj10EF2mew130_provenance.
• assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP689541.RA9bbvgXWaa3FkXztNIXToWFx_5sDEJ2yjkysuuHIVBWk130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689541.RA9bbvgXWaa3FkXztNIXToWFx_5sDEJ2yjkysuuHIVBWk130_provenance.
• NP300901.RATxZ5FRVzlxZsOAmlWLjjb-ej8tdofKNlyRWE7RSZM94130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300901.RATxZ5FRVzlxZsOAmlWLjjb-ej8tdofKNlyRWE7RSZM94130_provenance.
• NP625470.RAMJpJriTVWjRN5SLXKvK-w8VlRR30tTwOOvZZdNJ9WA8130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625470.RAMJpJriTVWjRN5SLXKvK-w8VlRR30tTwOOvZZdNJ9WA8130_provenance.
• NP907595.RAUGn9dHDksMrpL5TnN0NYpDE8lOKugHac1t9OvHBQLIg130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907595.RAUGn9dHDksMrpL5TnN0NYpDE8lOKugHac1t9OvHBQLIg130_provenance.
• assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP815614.RACiQC7cnmsEvt3sd-l-1xMMVwg7YN7EnIvxdr63JPtII130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815614.RACiQC7cnmsEvt3sd-l-1xMMVwg7YN7EnIvxdr63JPtII130_provenance.
• NP815622.RADNSjuzn3IRqo4tFYC79vsopl_dYnt84QBQ4NjUzXOCs130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815622.RADNSjuzn3IRqo4tFYC79vsopl_dYnt84QBQ4NjUzXOCs130_provenance.
• NP815619.RAXiTbBnVSgxkxaWIf537eml0gBxiH4SvKgyVn8POEaUk130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815619.RAXiTbBnVSgxkxaWIf537eml0gBxiH4SvKgyVn8POEaUk130_provenance.
• assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP907597.RABjuf7jw7HY9ISURUuTbnZzT6kaKDziBuCkQwTSGxFg0130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907597.RABjuf7jw7HY9ISURUuTbnZzT6kaKDziBuCkQwTSGxFg0130_provenance.
• NP1004449.RAt-Fz3ufRssLeR1KbcaI4oHQ72i_Kg6u0X0jWIm80bjQ130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1004449.RAt-Fz3ufRssLeR1KbcaI4oHQ72i_Kg6u0X0jWIm80bjQ130_provenance.
• NP957520.RAk0x9-wur4WOOTss-bks6NhRUEvu16xwa5bvrobnE8xE130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957520.RAk0x9-wur4WOOTss-bks6NhRUEvu16xwa5bvrobnE8xE130_provenance.
• NP815617.RAsKYiaSC9Oj2iuE-5ge8uCZFjcNVwl4gTqLTgrwVb5aM130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815617.RAsKYiaSC9Oj2iuE-5ge8uCZFjcNVwl4gTqLTgrwVb5aM130_provenance.
• NP261092.RAzb7POEXIIHIb_gIV1xUhpqM3Vi33i24ADc-DX9tLlu4130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP261092.RAzb7POEXIIHIb_gIV1xUhpqM3Vi33i24ADc-DX9tLlu4130_provenance.
• NP300925.RA8FN-OYXKkYAYPIeKiT2R1A528GsnaiiaZdMoJbT3MQk130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300925.RA8FN-OYXKkYAYPIeKiT2R1A528GsnaiiaZdMoJbT3MQk130_provenance.
• NP957501.RAOpWjXme4l20Y5xcIOKgtbLnZHapH0QKOh2RhTWQGwe8130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957501.RAOpWjXme4l20Y5xcIOKgtbLnZHapH0QKOh2RhTWQGwe8130_provenance.
• NP815610.RAEsrzoGwDb8-B9yqhhcUtbrAPZxnuf-rLqCZgKp2SfRc130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815610.RAEsrzoGwDb8-B9yqhhcUtbrAPZxnuf-rLqCZgKp2SfRc130_provenance.
• NP815616.RANIJ7UNpaAXRqF9pTgHUEXknnqUE3A9AsniQxTSaSalE130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815616.RANIJ7UNpaAXRqF9pTgHUEXknnqUE3A9AsniQxTSaSalE130_provenance.
• NP815618.RAIclix14FPcXwyjZwydvN3VS_EtkmYTTO4AH0cFaaKGA130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815618.RAIclix14FPcXwyjZwydvN3VS_EtkmYTTO4AH0cFaaKGA130_provenance.
• NP815621.RAPUL-tpWMO-sFO-jIGZKOOosqcJ6Sk7rNDp6BblP2GF8130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815621.RAPUL-tpWMO-sFO-jIGZKOOosqcJ6Sk7rNDp6BblP2GF8130_provenance.
• NP815624.RAHZLVILz6COqg92dclQAIzmOIZCKVU0REUr3kjrUXYIw130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815624.RAHZLVILz6COqg92dclQAIzmOIZCKVU0REUr3kjrUXYIw130_provenance.
• NP1004430.RA7PO67z-FoOptADOugnwuOSKe9ulFRMnRiwYjXpx9MDU130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1004430.RA7PO67z-FoOptADOugnwuOSKe9ulFRMnRiwYjXpx9MDU130_provenance.
• NP815609.RAyC8rjR2d7Fe4v-GMfjHUyGFNEuzDu_x2Caci5qhdetE130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815609.RAyC8rjR2d7Fe4v-GMfjHUyGFNEuzDu_x2Caci5qhdetE130_provenance.
• NP815611.RA8vrN_-tqc9TX0n6vKvePUw2gw7Z9HnM268WRFWgsZ4A130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815611.RA8vrN_-tqc9TX0n6vKvePUw2gw7Z9HnM268WRFWgsZ4A130_provenance.
• NP815612.RA3JBA9tbMg7AAoZ0w-mEArI3UlHNdnX1g1RRS8j_k8G0130_assertion description "[The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815612.RA3JBA9tbMg7AAoZ0w-mEArI3UlHNdnX1g1RRS8j_k8G0130_provenance.